【ChiCTR2600127910】Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
ChiCTR2600127910
尚未开始
/
/
/
2026-07-09
/
/
Dementia
Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
000000
1.To examine the effectiveness of an online psychosocial intervention in improving caregiving burden and care partners’ welling. 2.To study the care partners’ caregiving challenges and perception towards the intervention.
随机平行对照
其它
Informed consent will be sought from each participant who fulfilled the inclusion and exclusion criteria. After baseline assessment, each participant will be randomised into intervention group and control group. The randomisation ratio will be 1:1 for the best interest of the participants and to ensure the internal validity . Random numbers with a 1:1 intervention : control ratio will be generated using Excel by a researcher not involved in the subject recruitment and baseline assessment in order to avoid researcher bias. The random numbers will be generated before the start of participant recruitment, and then be given to the researchers who screen and recruit participants.
If the data is collected via researcher interview, the data collector will be blinded to group allocation to avoid bias.
N/A
/
145
/
2026-08-01
2031-07-31
/
1. Hong Kong citizens aged 18 or above; 2. Currently providing at least eight hours per week of daily care to a relative or friend with dementia (defined by AD8 >= 2) [8]; 3. Able to communicate in Cantonese; 4. Able to use online meeting platforms such as Zoom or Microsoft Teams; 5. No plan to admit the care recipients to long-term care facility in the coming six months; 6. Not participated in BPSD counselling in the past three months; 7. Not receiving BPSD-related case management; 8. Care recipient is living in community; 9. Care recipient is not using dementia-specific day care or residential care service; 10. Care recipient has no known terminal illness; 11. Care recipient is in mild to moderate stage of dementia, defined by stage 4-6 of Functional Assessment Staging [9]; 12. You are able to participate in the assessment in this research; 13. Consent to research participation. 1. Hong Kong citizens aged 18 or above; 2. Currently providing at least eight hours per week of daily care to a relative or friend with dementia (defined by AD8 >= 2) [8];3. Able to communicate in Cantonese; 4. Able to use online meeting platforms such as Zoom or Microsoft Teams;5. No plan to admit the care recipients to long-term care facility in the coming six months;6. Not participated in BPSD counselling in the past three months;7. Not receiving BPSD-related case management;8. Care recipient is living in community;9. Care recipient is not using dementia-specific day care or residential care service;10. Care recipient has no known terminal illness;11. Care recipient is in mild to moderate stage of dementia, defined by stage 4-6 of Functional Assessment Staging [9];12. You are able to participate in the assessment in this research;13. Consent to research participation.;
请登录查看1. Non Hong Kong citizen; 2. Major psychiatric issue at the time of recruitment that may need more intensive intervention than psychoeducation; 3. You are not able to participate in the assessment in this research; 4. Not giving consent to research participation.;
请登录查看Jockey Club Centre for Positive Ageing, the Chinese University of Hong Kong
000000
Jockey Club Centre for Positive Ageing, the Chinese University of Hong Kong的其他临床试验
The Chinese University of Hong Kong的其他临床试验
- 运动与脑刺激疗愈:促进居住于分间楼宇单位的注意力缺陷多动障碍儿童症状控制的三臂随机对照试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial
- A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong
- The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses
- An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial
- Effectiveness of acceptance-based diabetes self-management (ACT-DSM) for adults with type 2 diabetes for improving diabetes distress and glycaemic control: A randomised controlled trial
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- 一项关于声刺激增强慢波睡眠以改善失眠障碍睡眠质量的探索性研究
- The effects of art therapy-based intervention on anxiety children with haematological cancers: a randomised controlled trial
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial
- 养老院老年人使用3D打印髋部保护器的好处
- WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery
- 接纳与承诺疗法(ACT)减轻香港老年人孤独感的随机对照试验
- Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Hepatobiliary and Pancreatic surgery
- 针对中国农村认知障碍症患者家庭照顾者的适应性培训干预的有效性: 一项随机对照可行性试验
最新临床资讯
-
落地临床、抢滩院外,AI康复机器人下一步竞争拼什么?
动脉网-最新2026-08-29
-
再获国际权威学术认可!恒瑞创新药HRS-7535糖尿病肾病Ⅱ期临床研究发表于《柳叶刀》子刊
恒瑞医药2026-08-28
-
贵州百灵2026-08-28
-
癌度2026-08-28
-
UmabsDB2026-08-28
-
扬子江药业集团2026-08-28
-
医药观澜2026-08-28
-
金斯瑞生物2026-08-28
-
科凝生物 Pleryon2026-08-28
-
海创药业2026-08-28
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-30
-
2026-08-30
-
2026-08-30
-
摩熵咨询 20 8
-
摩熵咨询 34 36
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-31
-
2026-08-30
-
2026-08-29
-
摩熵咨询 35 45
-
摩熵咨询 28 45
-
摩熵咨询 34 23
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29

